Smallest effective dose of bupivacaine for chest surgery pain block
Part of Lungs & breathing, Pain clinical trials.
This trial tests the smallest amount of bupivacaine (a numbing medicine) needed to control pain after keyhole chest surgery. You will receive a nerve block before surgery, and the goal is to find the best dose with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are scheduled for video-assisted thoracoscopic surgery (VATS), a type of keyhole chest surgery
- You are in generally good health (ASA physical status I, II, or III)
- You are not allergic to local anesthetic medicines like bupivacaine
- You do not have severe lung disease or a bleeding disorder
- You are not pregnant and can communicate your pain levels after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a numbing medicine (liposomal bupivacaine) injected near the ribs can reduce pain after lung surgery. If you qualify, you may experience less pain and need fewer painkillers after your operation.
This study tests two different numbing techniques (nerve blocks) to see which one works better for pain relief after minimally invasive chest surgery. Both methods inject medicine near nerves to reduce post-surgery pain.
This study tests whether a special injection between the ribs can reduce pain after minimally invasive heart bypass surgery. The injection is given before surgery to help with pain control and may reduce the need for strong pain medicines.
This study tests a pain-relieving nerve block for the back (serratus posterior superior plane block) given before minimally invasive heart bypass surgery. It aims to see if this block helps with pain control and recovery after surgery.
This study compares two different types of nerve blocks (numbing injections near the ribs) to see which one works better for pain relief after minimally invasive chest surgery. Both techniques are standard care options, and the trial will help doctors understand which one provides the best pain control.
This trial is testing whether a numbing medicine called bupivacaine, given into the chest space during surgery, can reduce pain after minimally invasive chest surgery. It aims to find a better way to manage pain after the procedure.
Hear when a new Postoperative Pain Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.